Skip to main content
Caplight Logo









METAFORA Biosystems

METAFORA Biosystems

Private

Last Round

Grant

Jun 15, 2022

Total Funding Raised

$9.88M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

METAFORA Biosystems is a health-tech company that develops a single-cell analysis platform for the discovery, development, and distribution of diagnostic tests and cell therapy solutions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

flow cytometrysingle-cell analysiscytometry softwaremetabolic profilingin vitro diagnosticIVDcell therapyAI cytometryautomated gatingbiotech softwareclinical diagnosticsdigital pathologycomputational biologybioinformaticslab automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

METAFORA Biosystems Comparables

Compare METAFORA Biosystems with similar companies based on industry and business-model similarity.

METAFORA Biosystems comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ozette
83%
Cytolytics GmbH
79%
terraFlow
78%

METAFORA Biosystems Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 15, 2022
StrategicSep 16, 2021
GrantFeb 20, 2019
GrantJun 11, 2018

Key People

Founding team and executive leadership

Vincent Petit

CEO

Executive Team

Romain Kaspereit

General Manager, CFO

Executive Team

METAFORA Biosystems Investors

Notable investors and investment history

METAFORA Biosystems investors
InvestorRounds
European Innovation Council FundGrant
European CommissionGrant
BpifranceGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 212% MoM.

  • Jun 18, 2026

    Monthly visitors grew 31% MoM, from 216 to 284.

METAFORA Biosystems Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

METAFORA Biosystems Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about METAFORA Biosystems's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range28
Year Founded2011
Last FundingJun 15, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?